Chia‐Wei Chang
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 9
- Pluripotent Stem Cells Research 7
- Epigenetics and DNA Methylation 3
- Renal and related cancers 3
- RNA Interference and Gene Delivery 3
- Genetics top 10%
-
- CAR-T cell therapy research 13
-
- Acute Myeloid Leukemia Research 4
-
- Immune Cell Function and Interaction 3
- Co-authors
- Tim M. TownesKevin M. PawlikYi-Shin LaiYung LyouDirk SchübelerIchiro HirataniTomoki YokochiMichaela Schwaiger
- Journals
- Proceedings of the National Academy of Sciences (1 paper)SHILAP Revista de lepidopterología (2 papers)Blood (8 papers)
- Partner nations
- United StatesTaiwanGermany
In The Last Decade
Chia‐Wei Chang
30 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 1.1k
- Cancer Research 153
- Aging 13
- Genetics 178
- Oncology 155
Countries citing papers authored by Chia‐Wei Chang
This map shows the geographic impact of Chia‐Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Wei Chang more than expected).
Fields of papers citing papers by Chia‐Wei Chang
This network shows the impact of papers produced by Chia‐Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Wei Chang. The network helps show where Chia‐Wei Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chia‐Wei Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 24 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 72 | |
| 11 | 2016 | 23 | |
| 12 | 2015 | 9 | |
| 13 | 2015 | 88 | |
| 14 | 2014 | 25 | |
| 15 | 2013 | 4 | |
| 16 | 2011 | 28 | |
| 17 | 2009 | 41 | |
| 18 | 2009 | 46 | |
| 19 | 2008 | 424 | |
| 20 | A rare synovial sarcoma of the kidney exhibiting translocation (X;18) and SYT-SSX2 fusion gene. | 2002 | 12 |
About Chia‐Wei Chang
Chia‐Wei Chang is a scholar working on Oncology, Hematology and Immunology and Allergy, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), CRISPR and Genetic Engineering (9 papers), Pluripotent Stem Cells Research (7 papers), Acute Myeloid Leukemia Research (4 papers), Epigenetics and DNA Methylation (3 papers), Renal and related cancers (3 papers), RNA Interference and Gene Delivery (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Cancer Research (153 citations) and Aging (13 citations). Chia‐Wei Chang has collaborated with scholars based in United States, Taiwan and Germany. Frequent co-authors include Tim M. Townes, Kevin M. Pawlik, Yi-Shin Lai, Yung Lyou, Dirk Schübeler, Ichiro Hiratani, Tomoki Yokochi, Michaela Schwaiger, David M. Gilbert and Tyrone Ryba. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.